{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": 0.0, "regularMarketPrice": 12.9, "marketState": "REGULAR", "currency": "EUR", "exchange": "DUS", "shortName": "DT.BIOTECH INNOV.AG  O.N.", "longName": "Deutsche Biotech Innovativ AG", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "messageBoardId": "finmb_106670144", "regularMarketChange": 0.0, "regularMarketTime": 1683900079, "regularMarketDayHigh": 15.4, "regularMarketDayRange": "12.9 - 15.4", "regularMarketDayLow": 12.9, "regularMarketVolume": 35, "regularMarketPreviousClose": 12.9, "bid": 12.9, "ask": 22.8, "bidSize": 0, "askSize": 0, "fullExchangeName": "Dusseldorf", "financialCurrency": "EUR", "regularMarketOpen": 15.4, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 3.5999994, "fiftyTwoWeekLowChangePercent": 0.3870967, "fiftyTwoWeekRange": "9.3 - 69.5", "fiftyTwoWeekHighChange": -56.6, "fiftyTwoWeekHighChangePercent": -0.81438845, "fiftyTwoWeekLow": 9.3, "fiftyTwoWeekHigh": 69.5, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.18, "sharesOutstanding": 947296, "bookValue": 1.553, "fiftyDayAverage": 17.381, "fiftyDayAverageChange": -4.481001, "fiftyDayAverageChangePercent": -0.2578103, "twoHundredDayAverage": 29.80525, "twoHundredDayAverageChange": -16.90525, "twoHundredDayAverageChangePercent": -0.56719035, "marketCap": 60153344, "priceToBook": 8.306503, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1343282400000, "priceHint": 2, "symbol": "DBI.DU"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Neuendorfstrasse 15a", "city": "Hennigsdorf", "zip": "16761", "country": "Germany", "phone": "49 3302 20 77 824", "fax": "49 3302 20 77 815", "website": "https://www.dbi-ag.de", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Deutsche Biotech Innovativ AG operates as a biotechnology company in Germany. The company develops Adrecizumab, an antibody-based therapy which is in Phase I/II clinical trial for the treatment of septic shock. It also focuses on the development of various drugs for the treatment of solid tumor, organ failure, rosacea, neurodermatitis, pharyngitis, and Alzheimer's diseases. The company was formerly known as Venetus Beteiligungen AG and changed its name to Deutsche Biotech Innovativ AG in August 2014. Deutsche Biotech Innovativ AG was founded in 2009 and is based in Hennigsdorf, Germany.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Bernd  Wegener FRICS", "age": 75, "title": "Chairman of Management Board & Chief Exec. Officer", "yearBorn": 1947, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Metod  Miklus", "age": 63, "title": "COO & Member of Management Board", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Frauke  Hein Ph.D.", "title": "Chief Bus. Officer & Head of Bus. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Joachim  Struck", "title": "Head of R&D", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jens  Zimmermann", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}